Physician profile
Brandy L Thomas
NPI 1275814469
$1,474.33
in general payments reported to CMS, 2019-2025
15 companies · $579 in 2025
The $579 reported for 2025 was more than what 96% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.20 · 2022: $93.63 · 2023: $260 · 2024: $527 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,365.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $458.87 | 2022-2025 | |
| Astellas Pharma US INC | $222.02 | 2024-2025 | Veozah |
| Biogen, INC. | $146.60 | 2025 | Zurzuvae |
| Abbvie INC. | $130.09 | 2022-2024 | |
| Hologic Sales and Service, LLC | $107.15 | 2022-2025 | Thinprep 2000 Processor, Aptima, Omni Hysteroscope |
| Amgen INC. | $102.87 | 2025 | Evenity |
| Pfizer INC. | $75.00 | 2024-2025 | |
| Exact Sciences Corporation | $69.01 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Baxter Healthcare | $46.33 | 2023 | Tisseel |
| Bayer Healthcare Pharmaceuticals INC. | $33.31 | 2021-2023 | |
| Coopersurgical, INC. | $19.83 | 2025 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $18.93 | 2025 | Myfembree |
| Exeltis, USA INC. | $18.15 | 2022 | |
| Coloplast Corp | $13.83 | 2025 | |
| Organon LLC | $12.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.